#h1CAR19-8BBζ T
Explore tagged Tumblr posts
Text
NexCAR19 CAR T Cell Therapy: Tailoring the Approach to B-Cell Lymphoma Treatment
NexCAR19 CAR T cell therapy is a groundbreaking treatment for B-cell lymphomas that has recently received approval in India. This innovative therapy harnesses the power of the patient's own immune system to fight cancer cells.
NexCAR19 is a CAR T cell therapy product that uses a unique humanized 'h1CAR19-8BBζ CAR' construct.
This construct favors CD4+ and CD8+ T cell subsets, cytokine secretion, and antitumor function.
Preclinical and clinical studies have demonstrated safety and remarkable efficacy in B-cell lymphoma patients.
Read more
#Actaly-Cel™#Actalycabtagene autoleucel#CAR T cell therapy by ImmunoACT India#h1CAR19-8BBζ T#ImmunoACT India#NexCAR19 by ImmunoACT India#NexCAR19 CAR T cell therapy for Lymphoma#Oncology healthcare India#regenerative health education#carttherapy#health education#health#health and wellness#medicine#healthcare#india#NexCAR19
1 note
·
View note